BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Jessica Taylor

  Jessica Taylor is a regulatory chemical manufacturing control specialist at Reckitt, where she is dedicated to ensuring the safety and compliance of global medicine production. The views expressed here are her own and do not reflect those of her employer.
• 

  Lung Cancer

  AbbVie’s ADC Nabs Accelerated Approval for Lung Cancer

  AbbVie’s Emrelis is the first non-small cell lung cancer therapy approved for patients with high c-Met expression levels who have received prior lines of treatment.

  May 15, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Manufacturing

  Sanofi Hops Aboard US Manufacturing Blitz With $20B Commitment

  Sanofi expects to add “a significant number of high-paying jobs” in the U.S. with $20 billion investment through 2030.

  May 15, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Now Hiring

  10 Companies Hiring in San Francisco

  Looking for a biopharma job in San Francisco? Check out the BioSpace list of 10 companies hiring life sciences professionals like you.

  May 15, 2025

   · 

  2 min read

   · 

  Angela Gabriel
• 

  Neurodegenerative disease

  FDA Delays Decision Date on Biohaven’s Spinocerebellar Ataxia Application

  The FDA also changed its tune and is now planning to convene an advisory committee to discuss Biohaven’s application.

  May 15, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Government

  RFK Jr. Firm on HHS Cuts, Wobbles on Measles Vaccine

  At a sometimes-contentious U.S. Senate hearing, the Health and Human Services secretary was evasive on the rationale behind cuts being made to the department and his endorsement of the measles vaccine amid a rapidly growing outbreak.

  May 15, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Deals

  Bluebird’s Private Equity Buyout Boosts Upfront Cash for Shareholders

  After warnings that the dragged-out process was putting the cell therapy company at risk of bankruptcy, bluebird bio now has a new deal to offer shareholders.

  May 15, 2025

   · 

  1 min read
• 

  FDA

  After FDA Cuts, Planning for Upcoming ODAC Meeting Has Been ‘Absolute Chaos’

  As the FDA prepares for a busy Oncologic Drugs Advisory Committee meeting next week, an agency insider told BioSpace that volunteers with little training are scrambling to secure the required expertise after workforce cuts decimated the adcomm planning office.

  May 15, 2025

   · 

  4 min read

   · 

  Heather McKenzie
• Press Releases

  Tisento Highlights Two Venues Advancing Patient-Focused Therapeutic Development for Mitochondrial Diseases

  May 15, 2025

   · 

  5 min read
• Press Releases

  BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson’s Disease on May 28, 2025

  May 15, 2025

   · 

  10 min read